When examining the known future for GMP compliance, there are a range of changes that the industry needs to brace for, including a new EU delegated act focused on investigational drug products.
In this infographic, Pharma IQ outlines the GMP updates the market will soon be facing.
Aspects discussed include:
- Future Annex 21 EU GMP Guide
- New Delegated Act impacting GMP for Investigational Medicinal Products for Human Use
- Future Annex 17 of EU GMP Guide Parametric Release
- Annex 1 of EU GMP Guide
- New GMP EU Guideline for Advanced Therapy Medicinal Products
- Transitional QPs and CTs
| Have Your Say Rate this feature and give us your feedback in the comments section below |